跳转至内容
Merck
CN

S3944

SEW2871

≥98% (HPLC), solid

别名:

5- [4-苯基-5-(三氟甲基)-2-噻吩基]-3- [3-(三氟甲基)苯基]-1,2,4-恶二唑

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C20H10F6N2OS
化学文摘社编号:
分子量:
440.36
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352211
MDL number:
Assay:
≥98% (HPLC)
Form:
solid
Quality level:
Storage condition:
protect from light
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

SEW2871, ≥98% (HPLC), solid

InChI

1S/C20H10F6N2OS/c21-19(22,23)13-8-4-7-12(9-13)17-27-18(29-28-17)15-10-14(11-5-2-1-3-6-11)16(30-15)20(24,25)26/h1-10H

SMILES string

FC(F)(F)c1cccc(c1)-c2noc(n2)-c3cc(-c4ccccc4)c(s3)C(F)(F)F

InChI key

OYMNPJXKQVTQTR-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

solid

storage condition

protect from light

color

white

mp

94.5-95.3 °C

solubility

DMSO: ≥10 mg/mL
H2O: insoluble

storage temp.

2-8°C

Quality Level

Application

SEW2871可用于模拟HUVEC中的1-磷酸鞘氨醇的作用,以研究长穿透素3所产生的先天免疫力。
SEW2871已被用作鞘氨醇-1磷酸酯(S1P)受体激动剂,用于测定重构血浆载脂蛋白(ApoM) /S1P对小鼠血管通透性的作用。

Biochem/physiol Actions

SEW2871是1-磷酸鞘氨醇受体的选择性激动剂。其会通过显著延长室性心动过速和室颤的持续时间,加剧再灌注性心律失常。 SEW2871可通过影响淋巴细胞归巢和细胞迁移来调节炎症反应。 通过抑制促炎分子,SEW2871可减少因缺血引起的急性肾衰竭。
新型选择性人鞘氨醇-1-磷酸亚型1(S1P1)受体激动剂。

Features and Benefits

该化合物在受体分类和信号转导手册中 溶血磷脂受体 页面中进行了详细介绍。想要浏览手册的其他页面, 请单击此处

Packaging

光敏。

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Timothy M Doyle et al.
Pain, 161(9), 2107-2118 (2020-04-18)
Morphine-induced alterations in sphingolipid metabolism in the spinal cord and increased formation of the bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) have been implicated in the development of morphine-induced hyperalgesia (OIH; increased pain sensitivity) and antinociceptive tolerance. These adverse effects hamper opioid
Y-Hh Lien et al.
Kidney international, 69(9), 1601-1608 (2006-03-31)
The pathogenesis of renal ischemia/reperfusion (I/R) injury involves activating several signal transduction cascade systems in endothelial cells. Sphingosine 1-phospate (S1P) maintains endothelial cell integrity and inhibits lymphocyte egress via the specific S1P(1) receptor, and may play a role in reducing
David T Bolick et al.
Arteriosclerosis, thrombosis, and vascular biology, 25(5), 976-981 (2005-03-12)
Endothelial activation and monocyte adhesion to endothelium are key events in inflammation. Sphingosine-1-phosphate (S1P) is a sphingolipid that binds to G protein-coupled receptors on endothelial cells (ECs). We examined the role of S1P in modulating endothelial activation and monocyte-EC interactions
Zhoumou Chen et al.
Proceedings of the National Academy of Sciences of the United States of America, 116(21), 10557-10562 (2019-05-10)
Neuropathic pain afflicts millions of individuals and represents a major health problem for which there is limited effective and safe therapy. Emerging literature links altered sphingolipid metabolism to nociceptive processing. However, the neuropharmacology of sphingolipid signaling in the central nervous
Yayoi T Tsukada et al.
Journal of cardiovascular pharmacology, 50(6), 660-669 (2007-12-20)
Sphingosine-1-phosphate (S1P) has been considered to play an important role in ischemia/reperfusion (I/R) injury. We used SEW2871 (SEW), a novel receptor-selective agonist for S1P1, to elucidate the role of S1P1 in myocardial I/R. Isolated perfused rat hearts exposed to S1P

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持